Claims
- 1. A method of determining a haplotype of a subject, said method comprising providing an extended polynucleotide derived from said subject, said polynucleotide comprising a plurality of target sites that are each similarly labeled with at least a first unit-specific marker and a second unit-specific marker, wherein said at least first unit-specific marker and second unit-specific marker provide information for a haplotype in said subject;
moving the nucleic acid relative to a stationary detection station, and detecting said plurality of labeled sites at said detection station, thereby determining a haplotype of a subject.
- 2. The method of claim 1, wherein the target sites are base sequence variations selected from the group consisting of single nucleotide polymorphism, multibase deletion, multibase insertion, microsatellite repeats, dinucleotide repeats, tri-nucleotide repeats, sequence rearrangements, and chimeric sequence.
- 3. The method of claim 1, wherein the first and second unit specific markers are luminescent hybridization probes that have a distinguishable characteristic.
- 4. The method of claim 3, wherein the distinguishable characteristic is selected from the group consisting of luminescence emission spectral distribution, lifetime, intensity, burst duration, and polarization anisotropy.
- 5. The method of claim 3, wherein the luminescent hybridization probes comprise single dye molecules, energy transfer dye pairs, nano-particles, quantum dots, luminescent nano-crystals, intercalating dyes, or molecular beacons.
- 6. The method of claim 3, wherein each luminescent hybridization probe specifically hybridizes to one of the plurality of target sites.
- 7. The method of claim 6, wherein the luminescent hybridization probes are selected from the group consisting of DNA, RNA, locked nucleic acids, and peptide nucleic acids.
- 8. The method of claim 1, further comprising a third unit-specific marker, wherein said third unit-specific marker provides information for a haplotype in said subject.
- 9. The method of claim 8, further comprising a fourth unit-specific marker, wherein said fourth unit-specific marker provides information for a haplotype in said subject.
- 10. The method of claim 1, wherein the unit specific markers are single probes that are specific for each target or multiple probes that act together to identify the target.
- 11. The method of claim 10, wherein the single probes are selected from the group consisting of oligo DNA, oligo RNA, oligo beacon, oligo peptide nucleic acids, oligo locked nucleic acids, and chimeric oligos.
- 12. The method of claim 10, wherein the multiple probes are selected from the group consisting of hybridization pairs, invader oligo pairs, ligation oligo pairs, mismatch extension 5′-exonuclease oligo pairs, energy transfer oligo pairs, and 3′-exonuclease pairs.
- 13. The method of claim 1, wherein the nucleic acid is DNA.
- 14. The method of claim 13, wherein the nucleic acid is PCR amplified DNA.
- 15. The method of claim 1, wherein the stationary detection station is in optical communication with an avalanche photo diode or a charge coupled device.
- 16. The method of claim 14, wherein the nucleic acid is moved through the action of at least one molecular motor.
- 17. The method of claim 16, wherein the at least one molecular motor is a plurality of molecular motors in solution.
- 18. The method of claim 14, wherein the nucleic acid is moved through the action of hydrodynamic force.
- 19. The method of claim 14, wherein the detection station comprises at least one donor fluorophore and wherein a first unit specific marker and a second unit specific marker each comprise at least one acceptor fluorophore.
- 20. The method of claim 14, wherein the detection station comprises at least one acceptor fluorophore and wherein a first unit specific marker and a second unit specific marker each comprise at least one donor fluorophore.
- 21. The method of claim 1, wherein the detection station detects fluorescence resonance energy transfer.
- 22. The method of claim 1, wherein analysis of the nucleic acid provides information about the linear arrangement of target sites within the nucleic acid.
- 23. The method of claim 1, wherein the detection station detects the plurality of target sites of the nucleic acid simultaneously.
- 24. The method of claim 23, wherein the unit specific markers are detected by a confocal microscope.
- 25. The method of claim 23, wherein the plurality of sites are distinguished by labeling each of said plurality of sites with a different colored luminescent hybridization probe.
- 26. A method of determining a haplotype of a subject comprising moving an extended polynucleotide derived from said subject comprising a plurality of selected genetic markers that are each labeled with at least one distinguishable unit-specific marker, wherein said plurality of selected genetic markers provides information for a haplotype in said subject, through a channel;
exposing said plurality of labeled selected genetic markers to a detection station as the units move relative to the detection station, wherein said plurality of sites interact with the detection station to produce a detectable signal within the channel or at the edge of the channel; and detecting sequentially the signals resulting from said interaction to analyze the polynucleotide, thereby determining a haplotype of a subject.
- 27. The method of claim 26, wherein the detection station comprises an agent selected from the group consisting of electromagnetic radiation, a quenching source and a fluorescence excitation source.
- 28. The method of claim 27, wherein the agent comprises a fluorescence excitation source and said first unit-specific marker and said second unit-specific marker comprise fluorescent hybridization probes.
- 29. A method for determining a haplotype of a population of nucleic acids in a pool of nucleic acids comprising at least a first population and at least a second population, the method comprising:
providing a pool of extended polynucleotides, wherein the polynucleotides in a population comprises a plurality of target sites that are each similarly labeled with at least a first unit-specific marker and a second unit-specific marker, wherein said at least first unit-specific marker and second unit-specific marker provide information for a haplotype in said pool, further wherein the target sites are selected genetic markers; moving the polynucleotides of said pool past a stationary detection station; detecting the luminescent hybridization probes at the stationary detection station; and measuring said luminescent probes as the polynucleotides pass by the detectors, thereby determining the haplotype of the species of the polynucleotides in said pool.
- 30. The method of claim 29, wherein the target sites are base sequence variations selected from the group consisting of single nucleotide polymorphism, multibase deletion, multibase insertion, microsatellite repeats, dinucleotide repeats, tri-nucleotide repeats, sequence rearrangements, and chimeric sequence.
- 31. The method of claim 29, wherein the unit specific markers are luminescent hybridization probes that have a distinguishable characteristic.
- 32. The method of claim 31, wherein the distinguishable characteristic is selected from the group consisting of luminescence emission spectral distribution, lifetime, intensity, burst duration, and polarization anisotropy.
- 33. The method of claim 31, wherein the luminescent hybridization probes comprise single dye molecules, energy transfer dye pairs, nano-particles, quantum dots, luminescent nano-crystals, intercalating dyes, or molecular beacons.
- 34. The method of claim 31, wherein each luminescent hybridization probe specifically hybridizes to one of the plurality of target sites.
- 35. The method of claim 34, wherein the luminescent hybridization probes are selected from the group consisting of DNA, RNA, locked nucleic acids, and peptide nucleic acids.
- 36. The method of claim 29, further comprising a third unit-specific marker, wherein said third unit-specific marker provides information for a haplotype in said pool.
- 37. The method of claim 36, further comprising a fourth unit-specific marker, wherein said fourth unit-specific marker provides information for a haplotype in said pool.
- 38. The method of claim 29, wherein the unit specific markers are single probes that are specific for each target or multiple probes that act together to identify the target.
- 39. The method of claim 38, wherein the single probes are selected from the group consisting of oligo DNA, oligo RNA, oligo beacon, oligo peptide nucleic acids, oligo locked nucleic acids, and chimeric oligos.
- 40. The method of claim 38, wherein the multiple probes are selected from the group consisting of hybridization pairs, invader oligo pairs, ligation oligo pairs, mismatch extension 5′-exonuclease oligo pairs, energy transfer oligo pairs, and 3′-exonuclease pairs.
- 41. The method of claim 29, wherein the polynucleotides are DNA.
- 42. The method of claim 29, wherein the stationary detection station is in optical communication with an avalanche photo diode or a charge coupled device.
- 43. The method of claim 29, wherein the detection station detects fluorescence resonance energy transfer.
- 44. The method of claim 29, wherein the detection station comprises at least one donor fluorophore and wherein a first unit specific marker and a second unit specific marker each comprise at least one acceptor fluorophore.
- 45. The method of claim 29, wherein the detection station comprises at least one acceptor fluorophore and wherein a first unit specific marker and a second unit specific marker each comprise at least one donor fluorophore.
- 46. The method of claim 29, wherein the plurality of sites are distinguished by labeling each of said plurality of sites with a different colored luminescent hybridization probe.
- 47. The method of claim 29, wherein said first population comprises polynucleotides from one individual and said second population comprises polynucleotides from a different individual.
- 48. The method of claim 29, wherein said first population comprises polynucleotides from a healthy state of a subject and said second population comprises polynucleotides from a disease state of the same subject.
- 49. A method of determining a haplotype of a subject, said method comprising
providing a polynucleotide, a first ligation oligonucleotide and a second ligation oligonucleotide, wherein said first ligation oligonucleotide is associated with a first labeled moiety and includes a first constant sequence complementary to a sequence in the target polynucleotide that provides information for a haplotype in said subject, a query nucleotide at the 3′ terminus of said first ligation polynucleotide and, optionally, a mismatch oligonucleotide adjacent to said query nucleotide; and wherein said second ligation oligonucleotide is associated with a second labeled moiety and includes a second constant sequence complementary to a sequence in the target polynucleotide that provides information for a haplotype in said subject, a query nucleotide at the 3′ terminus of said second ligation polynucleotide and, optionally, a mismatch oligonucleotide adjacent to said query nucleotide; annealing an effective amount of said first ligation oligonucleotide to said polynucleotide to yield a primed first template; combining the primed template with an effective amount of a polymerase enzyme and at least two types of nucleotide triphosphates, under conditions sufficient for polymerase activity, thereby forming a first elongated polynucleotide; annealing an effective amount of said second ligation oligonucleotide to said polynucleotide to yield a primed second template; combining the primed second template with an effective amount of a polymerase enzyme and at least two types of nucleotide triphosphates, under conditions sufficient for polymerase activity, thereby forming a second elongated polynucleotide; extending said elongated first polynucleotide and said elongated second polynucleotide; and detecting said first labeled moiety and second labeled moiety, thereby determining a haplotype.
RELATED APPLICATIONS
[0001] This application claims priority from Provisional Application U.S. S. No. 60/379,461, filed May 9, 2002 which is incorporated by reference in its entirety.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60379461 |
May 2002 |
US |